These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8992429)
1. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)]. Döbrönte Z; Juhász L; Tulassay Z Orv Hetil; 1996 Oct; 137(42):2309-12. PubMed ID: 8992429 [TBL] [Abstract][Full Text] [Related]
2. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400 [TBL] [Abstract][Full Text] [Related]
3. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography. Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631 [TBL] [Abstract][Full Text] [Related]
4. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP. Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522 [TBL] [Abstract][Full Text] [Related]
5. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155 [TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967 [TBL] [Abstract][Full Text] [Related]
7. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis. Kisli E; Baser M; Aydin M; Guler O Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271 [TBL] [Abstract][Full Text] [Related]
8. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865 [TBL] [Abstract][Full Text] [Related]
13. Effect of somatostatin on hyperamylasemia following endoscopic pancreatography. Tydén G; Nyberg B; Sonnenfeld T; Thulin L Acta Chir Scand Suppl; 1986; 530():43-5. PubMed ID: 2425529 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of post-ERCP acute pancreatitis with octreotide]. Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209 [TBL] [Abstract][Full Text] [Related]
15. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla. Testoni PA; Lella F; Bagnolo F; Caporuscio S; Cattani L; Colombo E; Buizza M Pancreas; 1996 Jul; 13(1):61-5. PubMed ID: 8783335 [TBL] [Abstract][Full Text] [Related]
16. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy. Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351 [TBL] [Abstract][Full Text] [Related]
17. [Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia]. Liu CG; Leng DY; Liu H Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):607-10. PubMed ID: 19852292 [TBL] [Abstract][Full Text] [Related]
18. The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Tulassay Z; Papp J Gastrointest Endosc; 1991; 37(1):48-50. PubMed ID: 1706282 [TBL] [Abstract][Full Text] [Related]
19. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015 [TBL] [Abstract][Full Text] [Related]
20. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]